Literature DB >> 24760838

Crtc1 activates a transcriptional program deregulated at early Alzheimer's disease-related stages.

Arnaldo Parra-Damas1, Jorge Valero, Meng Chen, Judit España, Elsa Martín, Isidro Ferrer, José Rodríguez-Alvarez, Carlos A Saura.   

Abstract

Cognitive decline is associated with gene expression changes in the brain, but the transcriptional mechanisms underlying memory impairments in cognitive disorders, such as Alzheimer's disease (AD), are largely unknown. Here, we aimed to elucidate relevant mechanisms responsible for transcriptional changes underlying early memory loss in AD by examining pathological, behavioral, and transcriptomic changes in control and mutant β-amyloid precursor protein (APPSw,Ind) transgenic mice during aging. Genome-wide transcriptome analysis using mouse microarrays revealed deregulation of a gene network related with neurotransmission, synaptic plasticity, and learning/memory in the hippocampus of APPSw,Ind mice after spatial memory training. Specifically, APPSw,Ind mice show changes on a cAMP-responsive element binding protein (CREB)-regulated transcriptional program dependent on the CREB-regulated transcription coactivator-1 (Crtc1). Interestingly, synaptic activity and spatial memory induces Crtc1 dephosphorylation (Ser151), nuclear translocation, and Crtc1-dependent transcription in the hippocampus, and these events are impaired in APPSw,Ind mice at early pathological and cognitive decline stages. CRTC1-dependent genes and CRTC1 levels are reduced in human hippocampus at intermediate Braak III/IV pathological stages. Importantly, adeno-associated viral-mediated Crtc1 overexpression in the hippocampus efficiently reverses Aβ-induced spatial learning and memory deficits by restoring a specific subset of Crtc1 target genes. Our results reveal a critical role of Crtc1-dependent transcription on spatial memory formation and provide the first evidence that targeting brain transcriptome reverses memory loss in AD.

Entities:  

Keywords:  CREB; TORC; gene expression; memory; neurodegeneration; β-amyloid

Mesh:

Substances:

Year:  2014        PMID: 24760838      PMCID: PMC6608295          DOI: 10.1523/JNEUROSCI.5288-13.2014

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  35 in total

1.  Intraneuronal Amyloid Beta Accumulation Disrupts Hippocampal CRTC1-Dependent Gene Expression and Cognitive Function in a Rat Model of Alzheimer Disease.

Authors:  Edward N Wilson; Andrew R Abela; Sonia Do Carmo; Simon Allard; Adam R Marks; Lindsay A Welikovitch; Adriana Ducatenzeiler; Yogita Chudasama; A Claudio Cuello
Journal:  Cereb Cortex       Date:  2017-02-01       Impact factor: 5.357

Review 2.  Synaptically Localized Transcriptional Regulators in Memory Formation.

Authors:  Shusaku Uchida; Gleb P Shumyatsky
Journal:  Neuroscience       Date:  2017-07-18       Impact factor: 3.590

3.  CRTC1 Nuclear Translocation Following Learning Modulates Memory Strength via Exchange of Chromatin Remodeling Complexes on the Fgf1 Gene.

Authors:  Shusaku Uchida; Brett J W Teubner; Charles Hevi; Kumiko Hara; Ayumi Kobayashi; Rutu M Dave; Tatsushi Shintaku; Pattaporn Jaikhan; Hirotaka Yamagata; Takayoshi Suzuki; Yoshifumi Watanabe; Stanislav S Zakharenko; Gleb P Shumyatsky
Journal:  Cell Rep       Date:  2017-01-10       Impact factor: 9.423

4.  Non-canonical activation of CREB mediates neuroprotection in a Caenorhabditis elegans model of excitotoxic necrosis.

Authors:  K Genevieve Feldmann; Ayesha Chowdhury; Jessica L Becker; N'Gina McAlpin; Taqwa Ahmed; Syed Haider; Jian X Richard Xia; Karina Diaz; Monal G Mehta; Itzhak Mano
Journal:  J Neurochem       Date:  2018-12-20       Impact factor: 5.372

Review 5.  Deregulation of CRTCs in Aging and Age-Related Disease Risk.

Authors:  Caroline C Escoubas; Carlos G Silva-García; William B Mair
Journal:  Trends Genet       Date:  2017-03-30       Impact factor: 11.639

Review 6.  N-Palmitoylethanolamine and Neuroinflammation: a Novel Therapeutic Strategy of Resolution.

Authors:  Stephen D Skaper; Laura Facci; Massimo Barbierato; Morena Zusso; Giuseppe Bruschetta; Daniela Impellizzeri; Salvatore Cuzzocrea; Pietro Giusti
Journal:  Mol Neurobiol       Date:  2015-06-09       Impact factor: 5.590

Review 7.  Nuclear receptors in neurodegenerative diseases.

Authors:  Rebecca Skerrett; Tarja Malm; Gary Landreth
Journal:  Neurobiol Dis       Date:  2014-05-27       Impact factor: 5.996

Review 8.  Contemporary Animal Models For Human Gene Therapy Applications.

Authors:  Chitra Gopinath; Trupti Job Nathar; Arkasubhra Ghosh; Dennis Durand Hickstein; Everette Jacob Remington Nelson
Journal:  Curr Gene Ther       Date:  2015       Impact factor: 4.391

9.  Salivary exRNA biomarkers to detect gingivitis and monitor disease regression.

Authors:  Karolina E Kaczor-Urbanowicz; Harsh M Trivedi; Patricia O Lima; Paulo M Camargo; William V Giannobile; Tristan R Grogan; Frederico O Gleber-Netto; Yair Whiteman; Feng Li; Hyo Jung Lee; Karan Dharia; Katri Aro; Carmen Martin Carreras-Presas; Saarah Amuthan; Manjiri Vartak; David Akin; Hiba Al-Adbullah; Kanika Bembey; Perry R Klokkevold; David Elashoff; Virginia M Barnes; Rose Richter; William DeVizio; James G Masters; David T W Wong
Journal:  J Clin Periodontol       Date:  2018-06-15       Impact factor: 8.728

10.  The HDAC inhibitor SAHA improves depressive-like behavior of CRTC1-deficient mice: Possible relevance for treatment-resistant depression.

Authors:  Elsa M Meylan; Olivier Halfon; Pierre J Magistretti; Jean-René Cardinaux
Journal:  Neuropharmacology       Date:  2016-03-09       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.